G21.19

Other drug induced secondary parkinsonism

Billable / specific

G21.19 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.

Inclusion terms

Applicable to

  • Other medication-induced parkinsonism

Excludes1

Not coded here — never report together with this code.

  • Huntington's disease (G10) (from G21)
  • neurocognitive disorder with Lewy bodies (G31.83) (from G21)
  • Shy-Drager syndrome (G90.3) (from G21)
  • syphilitic Parkinsonism (A52.19) (from G21)

Excludes2

Not included here — may be reported together when both conditions exist.

  • certain conditions originating in the perinatal period (P04-P96) (from G21)
  • certain infectious and parasitic diseases (A00-B99) (from G21)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A) (from G21)
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) (from G21)
  • endocrine, nutritional and metabolic diseases (E00-E88) (from G21)
  • injury, poisoning and certain other consequences of external causes (S00-T88) (from G21)
  • neoplasms (C00-D49) (from G21)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) (from G21)

Use additional code

Add a code to identify the following, if applicable.

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Also known as

  • Other medication-induced parkinsonism
  • Parkinsonism, due to drugs NEC
  • Parkinsonism, medication-induced NEC
  • Parkinsonism, secondary, due to drugs NEC
  • Parkinsonism, treatment-induced NEC

Parent code

  • G21.1Other drug-induced secondary parkinsonismHeader

Related codes

  • G21.11Neuroleptic induced parkinsonismBillable

Browse